Apoptosis in polycystic kidney disease: Involvement of caspases

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Ali, Shujath M ^a   Wong, Victoria Y ^a   Kikly, Kristine ^a   Fredrickson, Todd A ^a   Keller, Paul M ^a   DeWolf Jr , Walter E ^a   Lee, Dennis ^a   Brooks, David P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cpk mice; Cysteine proteases

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY INTERSTITIUM; KIDNEY POLYCYSTIC DISEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034098936     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.3.r763     Document Type: Article

References (50)

1. Alnemri, E. S. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J. Cell. Biochem. 64: 33-42, 1997.
2. Aziz, N. Animal models of polycystic kidney disease. Bioessays 17: 703-712, 1995.
3. Bycroft, M., A. Bateman, J. Clarke, S. J. Hamill, R. Sandford, R. L. Thomas, and C. Chothia. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO 18: 297-305, 1999.
4. Calvet, J. P. Molecular genetics of polycystic kidney disease. J. Nephrol. 11: 24-34, 1998.
5. Cowley, B. D., L. J. Chadwick, J. J. Grantham, and J. P. Calvet. Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J. Am. Soc. Nephrol. 1: 1048-1053, 1991.
6. Davisson, M. T., L. M. Guay-Woodford, H. W. Harris, and P. D'Eustachio. The mouse polycystic kidney disease mutation (cpk) is located on proximal chromosome 12. Genomics 4: 778-781, 1991.
7. Fry, J., W. Koch, J. Jennette, E. McFarland, F. Fried, and J. Mandell. A genetically determined murine model of infantile polycystic kidney disease. J. Urol. 134: 828-833, 1985.
8. Gabow, P. A. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 329: 332-342, 1993.
9. Gattone, V. H, II, J. P. Calvet, B. D. Cowley, Jr., A. P. Evan, T. S. Shaver, K. Helmstader, and J. J. Grantham. Autosomal recessive polycystic kidney disease in a murine model. A gross and microscopic description. Lab. Invest. 59: 231-238, 1988.
10. Glucksmann-Kuis, M. A., O. Tayber, E. A. Woolf, L. Bougueleret, N. Deng, G. D. Alperin, F. Iris, F. Hawkins, C. Munro, N. Lakey, G. Duyk, M. C. Schneider, L. Geng, F. Zhang, Z. Zhao, S. Torosian, J. Zhou, S. T. Reeders, P. Bork, M. Pohlschmidt, C. Lohning, B. Kraus, U. Nowicka, A. L. S. Leung, and A.-M. Frischau. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995.
11. Grantham, J. J. Polycystic kidney disease-there goes the neighborhood. N. Engl. J. Med. 333: 56-57, 1995.
12. Hakem, R., A. Hakem, G. S. Duncan, J. T. Henderson, M. Woo, M. S. Soengas, A. Elia, J. L. de la Pompa, D. Kagi, W. Khoo, J. Potter, R. Yoshida, S. A. Kaufman, S. W. Lowe, J. M. Penninger, and T. W. Mak. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352, 1998.
13. Hirata, H., A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187: 587-600, 1998.
14. Hughes, J., C. J. Ward, B. Peral, R. Aspinwall, K. Clark, J. L. San Millan, V. Gamble, and P. C. Harris. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10: 151-160, 1995.
15. Jacobson, M. D., M. Weil, and M. C. Raff. Role of Ced-3/ICE-family proteases in staurosproine-induced programmed cell death. J. Cell. Biol. 133: 1041-1051, 1996.
16. Kidd, V. J. Proteolytic activities that mediate apoptosis. Annu. Rev. Physiol. 60: 533-573, 1998.
17. Kimberling, W. J., S. Kumar, P. A. Gabow, J. B. Kenyon, C. J. Connolly, and S. Somlo. Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-123. Genomics 18: 467-472, 1993.
18. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997..
19. Kroemer, G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3: 614-620, 1997.
20. Kuida, K., T. F. Haydar, C. Y. Kuan, Y. Gu, C. Taya, H. Karasuyama, M. S. Su, P. Rakic, and R. A. Flavell. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94: 325-337, 1998.
21. Lanoix, J., V. D'Agati, M. Szabolcs, and M. Trudel. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogens 13: 1153-1160, 1996.
22. Longthorne, V. L., and G. T. Williams. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO 16: 3805-3812, 1997.
23. Marcelli, M., G. R. Cunningham, S. J. Haidacher, S. J. Padayatty, L. Sturgis, C. Kagan, and L. Denner. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 58: 76-83, 1998.
24. Martinez, J. R., B. D. Cowley, V. H. Gattone, II, S. Nagao, T. Yamaguchi, S. Kaneta, H. Takahashi, and J. J. Grantham. The effect of paclitaxel on the progression of polycystic kidney disease in rodents. Am, J. Kidney Dis. 29: 435-444, 1997.
25. Mills, J. C., V. M. Lee, and R. N. Pittman. Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. J. Cell Sci. 111: 625-636, 1998.
26. Mochizuki, T., G. Wu, T. Hayashi, S. L. Xenophontos, B. Veldhuisen, J. J. Saris, D. M. Reynolds, Y. Cai, P. A. Gabow, A. Pierides, W. J. Kimberling, M. H. Breuning, C. C. Deltas, D. J. M. Peters, and S. Somlo. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996.
27. Nuñez, G., M. A. Benedict, Y. Hu, and N. Inohara. Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237-3245, 1998.
28. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
29. Porter, A. G., P. Ng, and R. U. Jänicke. Death substrates come alive. Bioessays 19: 501-507, 1997.
30. Prasad, S., V. A. Soldatenkov, G. Srinivasarao, and A. Dritschilo. Intermediate filament proteins during carcinogenesis and apoptosis (review). Int. J. Oncol. 14: 563-570, 1999.
31. Qian, F., F. J. Germino, Y. Cai, X. Zhang, S. Somlo, and G. G. Germino. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 16: 179-183, 1997.
32. Reed, J. C. Bcl-2 family proteins. Oncogene 17: 3225-3236, 1998.
33. Reeders, S. T., M. H. Breuning, K. E. Davies, R. D. Nichols, A. P. Jarman, D. R. Higgs, P. L. Pearson, and D. J. Weatherall. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317: 542-544, 1985.
34. Rodriguez, I., K. Matsuura, C. Ody, S. M. Nagata, and P. Vassalli. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184: 2067-2072, 1996..
35. Salvesen, G. S., and V. M. Dixit. Caspasess: intracellular signaling by proteolysis. Cell 91: 443-446, 1997.
36. Sedlak, T. W., Z. N. Oltvai, E. Yang, K. Wang, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92: 7834-7838, 1995.
37. Shimizu, T., and Y. Pommier. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Leukemia: 1238-1244, 1997.
38. Sorenson, C. M., B. J. Padanilam, and M. R. Hammerman. Abnormal postpartum renal development and cystogenesis in the bcl-2(-/-) mouse. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 271: F184-F193, 1996.
39. Trudel, M., J. Lanoix, L. Barisoni, M. J. Blouin, M. Desforges, C. L'Italien, and V. D'Agati. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186: 1873-1884, 1997.
40. Varfolomeev, E. E., M. Schuchmann, V. Luria, N. Chiannilkulchai, J. S. Beckmann, I. L. Mett, D. Rebrikov, V. M. Brodianski, O. C. Kemper, O. Kollet, T. Lapidot, D. Soffer, T. Sobe, K. B. Avraham, T. Goncharov, H. Holtmann, P. Lonai, and D. Wallach. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276, 1998.
41. Veis, D. J., C. M. Sorenson, J. R. Shutter, and S. J. Korsmeyer. Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240, 1993.
42. Ward, C. J., B. Peral, J. Hughes, S. Thomas, V. Gamble, A. B. MacCarthy, J. Sloane-Stanley, V. J. Buckle, L. Kearney, D. R. Higgs, P. J. Ratcliffe, P. C. Harris, J. H. Roelfsema, L. Spruit, J. J. Saris, H. G. Dauwerse, D. J. M. Peters, M. H. Breuning, M. Nellist, P. T. Brook-Carter, M. M. Maheshwar, I. Cordeiro, H. Santos, P. Cabral, J. R. Sampson, B. Janssen, A. L. W. Hesseling-Janssen, A. M. W. vanden Ouweland, B. Eussen, S. Verhoef, D. Lindhout, and D. J. J. Halley. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 881-894, 1994.
43. Woo, D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 333: 18-25, 1995.
44. Woo, D. D. L., S. Y. P. Miao, J. C. Pelayo, and A. S. Woolf. Taxol inhibits progression of congenital polycystic kidney disease. Nature 368: 750-753, 1994.
45. Woo, D. D. L., A. P. Tabancay, Jr., and C. J. N. Wang. Microtubule active taxanes inhibit polycystic kidney disease progression in cpk mice. Kidney Int. 51: 1613-1618, 1997.
46. Woo, M., R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kagi, A. Hakem, M. McCurrach, W. Khoo, S. A. Kaufman, G. Senaldi, T. Howard, S. W. Lowe, and T. W. Mak. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes & Dev. 12: 806-819, 1998.
47. Xiang, J., D. T. Chao, and S. J. Korsmeyer. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. 93: 14559-14563, 1996.
48. Yang, E., and S. J. Korsmeyer. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 88: 386-401, 1996.
49. Yin, X. M., Z. N. Oltvai, and S. J. Korsmeyer. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323, 1994.
50. Yue, T. L., C. Wang, A. M. Romanic, K. Kikly, P. Keller, W. E. J. DeWolf, T. K. Hart, H. C. Thomas, B. Storer, J. L. Gu, X. Wang, and G. Z. Feuerstein. Staurosporine-induced apoptosis in cardiomyocytes: a potential role of caspase-3. J. Mol. Cell. Cardiol. 30: 495, 1998.